The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling

NCT01340326 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: high dose of valsartan
DRUG: usual dose of valsartan

Sponsor

Dong-A University